# Ventoux Biosciences: Redefining Fibrosis Through Immune Modulation, Targeting Dupuytren and CNS Fibrosis

> Ventoux Biosciences advances immune\-fibrotic research, pioneering therapies across immunology and neurology to improve patient outcomes\.

Generated by Yoast SEO v28.1, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Support Our Mission](https://www.ventouxbio.com/support-dupuytrens-research/)
- [Scientific Advisory Board](https://www.ventouxbio.com/ventoux-biosciences-about-us/scientific-advisory-board/)
- [About](https://www.ventouxbio.com/ventoux-biosciences-about-us/)
- [Programs](https://www.ventouxbio.com/programs/)
- [Contact](https://www.ventouxbio.com/contact/)

## Posts
- [Progress in developing novel treatments for dupuytren's disease](https://www.ventouxbio.com/progress-in-developing-novel-treatments-for-dupuytrens-disease/)
- [Encouraging Progress In Our Dupuytren's Research](https://www.ventouxbio.com/encouraging-progress-in-our-dupuytrens-research/): At Ventoux Biosciences, we are making progress in our Dupuytren's research, aiming to transform the lives of millions affected by this condition\. Our approach with VEN\-201 targets the biological processes of Dupuytren's, not just the symptoms\. We've developed a laboratory model to test our therapy on human tissue, yielding promising early results\. As we prepare for clinical research, we invite you to join us \- whether by running, donating, or investing\. Together, we can bring hope to patients\.
- [New dupuytren's disease patent is a major milestone](https://www.ventouxbio.com/ventoux-biosciences-new-dupuytrens-disease-therapy-patent/): Ventoux Biosciences has announced the issuance of a U\.S\. patent for a new therapy targeting Dupuytren's disease and other immune\-fibrotic disorders\. This patent provides protection through 2044 and marks a major milestone for the company's efforts to develop disease\-modifying treatments\.

- [From patient to researcher: Professor jarad martin on radiation therapy and dupuytren's](https://www.ventouxbio.com/jarad-martin-patient-to-researcher-dupuytrens-radiation-therapy/)
- [Ventoux Biosciences Launches Research Program Targeting Spinal Cord Injury with VEN\-201](https://www.ventouxbio.com/ventoux-biosciences-launches-research-program-targeting-spinal-cord-injury-with-ven-201/)

## Categories
- [Dupuytren's Information](https://www.ventouxbio.com/category/dupuytrens-information/)
- [Company News](https://www.ventouxbio.com/category/company-news/)
- [Events](https://www.ventouxbio.com/category/events/)
- [Uncategorized](https://www.ventouxbio.com/category/uncategorized/)

## Optional
- [Sitemap index](https://www.ventouxbio.com/sitemap_index.xml)